Sign up
Pharma Capital

Orgenesis CEO says investors realizing building out infrastructure in biotechs is important

Orgenesis (NASDAQ:ORGS) CEO Vered Caplan spoke with Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Caplan participated in the forum's panel entitled "Cell and gene therapy: The financing surge."


View full ORGS profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.